Alterations in Sleep-wakefulness Cycle in Rats Following Treatment with (+)-lysergic Acid Diethylamide (LSD-25)

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1971 Feb 1

PMID 4324596

Citations 4

Authors

H Depoortere

D M Loew

Affiliations

Soon will be listed here.

Citing Articles

Ibogaine Acute Administration in Rats Promotes Wakefulness, Long-Lasting REM Sleep Suppression, and a Distinctive Motor Profile.

Gonzalez J, Prieto J, Rodriguez P, Cavelli M, Benedetto L, Mondino A Front Pharmacol. 2018; 9:374.

PMID: 29755349 PMC: 5934978. DOI: 10.3389/fphar.2018.00374.

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.

Schindler E, Wallace R, Sloshower J, DSouza D Front Pharmacol. 2018; 9:177.

PMID: 29545753 PMC: 5838010. DOI: 10.3389/fphar.2018.00177.

Proceedings: Alterations in the sleep-wakefulness cycle in rats after administration of (-)-LSD or BOL-148: a comparison with (+)-LSD.

Depoortere H, Loew D Br J Pharmacol. 1972; 44(2):354P-355P.

PMID: 4358412 PMC: 1666067.

Inhibition of reserpine-induced PGO waves in the cat by ergot derivatives.

Zuger P, Vigouret J, Loew D Experientia. 1978; 34(5):637-9.

PMID: 658255 DOI: 10.1007/BF01937007.

References

Dixon A . Evidence of catecholamine mediation in the "aberrant" behaviour induced by lysergic acid diethylamide (LSD) in the rat. Experientia. 1968; 24(7):743-7. DOI: 10.1007/BF02138352. View

Loew D, Depoortere H, Vigouret J . [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats]. Naunyn Schmiedebergs Arch Pharmakol. 1970; 266(4):394-5. View